Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioTime, Inc. (NY: BTX)
4.020 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about BioTime, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
BioTime Appoints Henry L. Nordhoff to Board of Directors
June 12, 2013
from Business Wire News Releases
BioTime, Inc. Closes on $9 Million Financing
June 07, 2013
from Business Wire News Releases
BioTime, Inc. to Raise $9 Million in Registered Direct Offering
June 03, 2013
from Business Wire News Releases
Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
May 23, 2013
The Israeli Office of the Chief Scientist Approved Cell Cure's Development Budget Totaling NIS 11.5 Million (Over $3 Million USD) with non equity based funding of close to 50% Read More
from PR Newswire
BioTime Announces Results of Vote at Special Meeting of Shareholders
May 23, 2013
from Business Wire News Releases
BioTime CEO Dr. Michael West to Present at USC Minisymposium: Musculoskeletal Development and Repair
May 20, 2013
from Business Wire News Releases
BioTime Appoints Franklin Berger to Board of Directors
May 14, 2013
from Business Wire News Releases
BioTime (BTX) Subsidiary Cell Cure Neurosciences Receives $1.5 Million Grant from Israeli Agency
May 14, 2013
category Stocks
from TransWorldNews Current Releases
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
May 13, 2013
from Business Wire News Releases
BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments
May 10, 2013
from Business Wire News Releases
PDL BioPharma Announces First Quarter 2013 Financial Results
May 09, 2013
from PR Newswire
BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research
May 07, 2013
from Business Wire News Releases
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
April 30, 2013
from PR Newswire
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.10
April 30, 2013
from Business Wire News Releases
BioTime Announces CFO Succession Plan
April 29, 2013
from Business Wire News Releases
LifeMap Sciences, a Subsidiary of BioTime, Announces Partnership with Appistry
April 23, 2013
from Business Wire News Releases
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
April 19, 2013
from Business Wire News Releases
LifeMap Sciences Announces Publication of Research Report Describing the MalaCards Database of Human Diseases
April 18, 2013
from Business Wire News Releases
LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene
April 10, 2013
from Business Wire News Releases
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap DiscoveryTM Version 1.1 with Enhanced Therapeutic Discovery and Commercial Utility
March 25, 2013
from Business Wire News Releases
BioTime Announces Fourth Quarter and Fiscal Year End 2012 Financial Results and Recent Corporate Accomplishments
March 18, 2013
from Business Wire News Releases
ExecRank Honors David Jin, M.D., Ph.D. of BioTime Inc. as a Top Chief Medical Officer for 2012
March 18, 2013
from Business Wire News Releases
BioTime to Present at 25th Annual ROTH Conference
March 13, 2013
from Business Wire News Releases
BioTime Appoints Stephen C. Farrell to Board of Directors
March 12, 2013
from Business Wire News Releases
BioTime and Romulus Agree to Accelerate Closing Date for Second Tranche of $5 Million Financing
March 07, 2013
from Business Wire News Releases
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success in 2012
March 06, 2013
RDInvesting Provides Stocks Research on BioTime and Merrimack Pharmaceuticals Read More
from Marketwired News Releases
BioTime and Subsidiary LifeMap Sciences Announce Data Mining Collaboration
March 04, 2013
from Business Wire News Releases
LifeMap Sciences, a Subsidiary of BioTime, Reports Its Databases Currently Utilized by an Estimated Two Million Unique Visitors Annually according to Google Analytics
February 11, 2013
from Business Wire News Releases
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
January 31, 2013
from Business Wire News Releases
LifeMap Sciences, a Subsidiary of BioTime, Announces Publication of Research Report Describing Non-Redundant Compendium of Human Non-Coding RNA Authored by GeneCards® Scientists
January 30, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here